Compare Pfizer Inc (PFE) vs ProShares UltraPro S&P500 (UPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs ProShares UltraPro S&P500 — how do they compare? Pfizer Inc trades at $27.9 (market cap $158.39B), while ProShares UltraPro S&P500 trades at $148.17. The key difference: Pfizer Inc pays a 6.19% dividend while ProShares UltraPro S&P500 pays none. Which is the better fit depends on your goals.
| PFE | UPRO | |
|---|---|---|
Market Cap | $158.39B | — |
Volume | 29,869,932 | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $29.02 | $157.66 |
52-Week Low | $23.60 | $89.29 |
Enterprise Value | $209.89B | — |
Dividend Yield | 6.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.
Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.
UPRO trades at $149.32, down 1.69% with neutral technical signals. The stock shows mixed technical indicators with bullish moving averages but neutral oscillators. Recent S&P 500 market discussions highlight AI-driven growth potential alongside concerns about high valuations and geopolitical risks. The stock faces support at $146 and resistance at $151, with overall market sentiment balanced between optimism and caution.
The outlook for UPRO remains tied to broader S&P 500 performance, with potential upside from AI productivity gains but risks from elevated valuations and interest rate uncertainty. Investors face a balanced risk-reward profile with technical support providing near-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About ProShares UltraPro S&P500
UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →
